title: Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
authors.forename: Marta Anna
authors.initials: MA
authors.lastname: Sobas
authors.forename: Natalia
authors.initials: N
authors.lastname: Alonso Vence
authors.forename: Jose
authors.initials: J
authors.lastname: Diaz Arias
authors.forename: Angeles
authors.initials: A
authors.lastname: Bendaña Lopez
authors.forename: Maximo
authors.initials: M
authors.lastname: Fraga Rodriguez
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Bello Lopez
mesh_terms: D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005871:Castleman Disease / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D016878:POEMS Syndrome / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib